Kuehn Law Encourages NS, NXPL, IP, and RXMD Investors to Contact Law Firm Kuehn Law investigates potential claims related to proposed mergers of NS, NXPL, IP, and RXMD. Shareholders urged to contact for details.

TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger – NS, CTLT, SCX, EVBG NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the...

ALERT: Juan Monteverde Encourages the Shareholders of TARO, BATL, NS, INBX to Take Action NEW YORK, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...

Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome Positive initial data and clean safety profile catalyze optimization planSize of both ongoing clinical trials significantly increasedLower dose eliminated from blinded trialDosing frequency changed to...